Corvex Other Income (Expense) increased by 89.0% to -$158.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 363.3%, from $60.00K to -$158.00K. Over 3 years (FY 2022 to FY 2025), Other Income (Expense) shows a downward trend with a 175.5% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $33.25K | $33.25K | $33.25K | $33.25K | $107.00K | $117.00K | $117.00K | $66.00K | $34.00K | $207.00K | $178.00K | $76.00K | $60.00K | $35.00K | -$1.44M | -$1.44M | -$158.00K |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +221.8% | +9.3% | +0.0% | -43.6% | -48.5% | +508.8% | -14.0% | -57.3% | -21.1% | -41.7% | <-999% | -0.1% | +89.0% |
| YoY Change | — | — | — | — | +221.8% | +251.9% | +251.9% | +98.5% | -68.2% | +76.9% | +52.1% | +15.2% | +76.5% | -83.1% | -907.9% | <-999% | -363.3% |